FDA Biologics (BLA & Biosimilars)Original article
2022 Center for Biologics Evaluation and Research (CBER) Science Symposium - 09/20/2022
ConferenceNeutral
AI Analysis
Summary
The FDA's Center for Biologics Evaluation and Research (CBER) held a public science symposium on September 20, 2022 to discuss scientific topics related to biologics regulation, featuring presentations by experts from academic institutions, government agencies, and research institutions.
Importance:2/10
Sentiment:
0.00
FDACBERRegulatoryConferenceScience Symposium
Read the original article
Published by FDA Biologics (BLA & Biosimilars) on September 10, 2026 4:10 PM